nasal
cultur
member
famili
nich
abl
persist
caus
seri
infect
rel
larg
number
famili
member
even
though
aureu
isol
activ
lesion
avail
test
recoveri
ident
pvlposit
organ
nasal
cultur
strongli
suggest
presenc
pathogen
clone
probabl
caus
recurr
infect
affect
famili
member
investig
highlight
high
transmiss
pvlproduc
aureu
clone
high
attack
rate
virul
intervent
outbreak
might
prevent
subsequ
recurr
cutan
infect
also
spread
clone
manifest
even
seriou
infect
necrot
pneumonia
increas
awar
among
communitybas
healthcar
provid
pvlproduc
aureu
infect
import
facilit
rapid
adequ
respons
similar
clinic
event
futur
treatment
vaccin
avail
rel
littl
research
conduct
pathogenesi
compar
arbovirus
dengu
recent
report
describ
massiv
outbreak
chikungunya
diseas
occur
island
indian
ocean
east
coast
africa
reemerg
chikungunya
also
report
indonesia
march
chines
man
hong
kong
visit
mauritiu
bitten
mosquito
day
return
hong
kong
return
trip
experienc
fever
sever
finger
joint
muscl
pain
mild
headach
skin
rash
sought
treatment
princ
wale
hospit
pwh
infecti
diseas
clinic
second
day
ill
physic
examin
show
gener
erythemat
rash
trunk
limb
petechia
lower
limb
mild
finger
joint
stiff
observ
joint
swell
lymphadenopathi
eschar
detect
level
creactiv
protein
elev
mgl
result
screen
malaria
dengu
neg
result
routin
assess
unremark
symptom
subsid
gradual
within
week
serum
specimen
taken
day
posit
chikungunya
viru
rna
inhous
revers
transcript
rt
pcr
public
health
laboratori
servic
phl
target
nonstructur
gene
pwh
laboratori
target
envelop
glycoprotein
gene
addit
serum
sampl
taken
day
ill
receiv
phl
also
posit
chikungunya
rna
laboratori
confirm
rtpcr
result
sequenc
pwh
phylogenet
analysi
perform
determin
like
origin
viru
inhous
immunofluoresc
slide
serolog
assay
develop
phl
found
chikungunya
immunoglobulin
g
igg
titer
serum
sampl
taken
day
ill
respect
detect
chikungunya
igm
day
serum
acut
cytokin
immunolog
respons
viru
also
test
onlin
appendix
avail
http
wwwcdcgov
apphtm
sequenc
phylogenet
analysi
consist
import
infect
almost
certainli
origin
current
chikungunya
outbreak
indian
ocean
phylogenet
analys
region
indic
viru
close
relat
previou
african
rather
southeast
asian
chikungunya
virus
see
onlin
appendix
figur
avail
http
wwwcdcgovncidodeid
http
wwwcdcgovncidodeid
persist
viremia
least
day
ill
unusu
standard
text
state
viremia
may
present
first
day
ill
neutral
antibodi
appear
day
strike
find
cytokin
analysi
tabl
high
level
induc
time
upper
limit
normal
rang
day
diseas
onset
respect
serum
concentr
monocyt
chemoattract
protein
mcp
monokin
induc
mig
also
elev
sampl
notabl
serum
tumor
necrosi
concentr
remain
within
normal
limit
sampl
although
concentr
local
inflammatori
site
eg
joint
unknown
concentr
decreas
clinic
recoveri
thu
cytokin
profil
demonstr
level
chemokin
highli
elev
level
chemokin
moder
elev
contrast
cytokin
elev
ill
interpret
signific
cytokin
result
necessarili
specul
comparison
made
viral
infect
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
influenza
infect
high
blood
level
moder
high
concentr
enhanc
express
vitro
report
dengu
fever
similar
clinic
manifest
chikungunya
fever
elev
concentr
shown
consist
although
express
studi
function
act
chemoattract
cell
activ
cellmedi
immun
respons
express
upregul
cytokin
acut
inflamm
implic
pathogenesi
sarscov
influenza
infect
persist
high
concentr
seem
correl
diseas
sever
progress
also
found
pathogen
role
influenza
sarscov
dengu
infect
notabl
level
antivir
cytokin
elev
chikungunya
case
though
admittedli
case
find
may
repres
way
chikungunya
viru
evad
host
defens
may
provid
rational
use
ifn
therapeut
option
ifn
therapi
suggest
tri
experiment
sarscov
dengu
infect
editor
august
laboratori
respons
network
lrn
establish
better
integr
improv
laboratori
capac
respond
public
health
threat
howev
expert
focus
clinic
indic
test
agent
bioterror
laboratori
method
microbi
identif
need
integr
commun
network
littl
attent
given
sentinel
laboratori
effect
screen
clinician
request
test
pathogen
design
global
health
threat
time
crisi
clinician
often
pressur
laboratorian
perform
test
patient
whose
probabl
diseas
low
nonvalid
sampl
type
case
anthrax
trigger
larg
number
nationwid
request
test
nasal
swab
bacillu
anthraci
despit
absenc
data
support
clinic
practic
outsid
epidemiolog
investig
similarli
falseposit
result
sever
acut
respiratori
syndrom
sar
nation
microbiolog
laboratori
canada
creat
public
alarm
sar
reemerg
viru
actual
common
respiratori
ill
nurs
home
problem
complic
laboratori
lrn
lack
standard
greater
access
nucleic
acid
amplificationbas
test
develop
test
global
health
threat
outsid
qualityregul
system
falseposit
result
caus
contamin
crossreact
microorgan
low
virul
disrupt
public
health
system
advers
affect
patient
care
increas
cost
falseneg
result
may
prompt
clinician
discontinu
contain
procedur
potenti
risk
transmit
virul
microorgan
sentinel
laboratori
recogn
challeng
took
step
promot
judici
use
test
agent
design
global
health
threat
report
use
algorithm
evalu
test
request
sarsassoci
coronaviru
highli
pathogen
avian
influenza
howev
algorithm
use
screen
test
request
pathogen
potenti
threaten
public
health
outbreak
sar
laboratori
protocol
establish
notifi
oncal
laboratori
profession
sampl
receiv
test
pathogen
figur
protocol
requir
laboratorian
commun
directli
clinician
use
script
question
base
criteria
establish
center
diseas
control
prevent
determin
medic
necess
test
sampl
patient
meet
criteria
reject
test
sar
use
inhous
realtim
pcr
assay
standard
laboratori
protocol
sampl
accept
test
screen
nonspecif
hemagglutinin
influenza
pcr
assay
result
posit
forward
lrn
laboratori
posit
result
report
confirm
lrn
laboratori
laboratori
profession
specif
train
sensit
specif
posit
predict
valu
neg
predict
valu
test
method
relat
sampl
type
time
symptom
onset
specimen
collect
diseas
preval
sampl
sar
receiv
test
sampl
test
clinician
respons
fail
satisfi
screen
criteria
remain
sampl
met
criteria
test
neg
result
